Relay announces plans for Phase 3 breast cancer trial of drug combination

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Relay announces plans for Phase 3 breast cancer trial of drug combination
(NASDAQ: RLAY) Delayed: 17.28 +1.40 (8.82%)
Previous Close $15.88    52 Week High $ 
Open $16.14    52 Week Low $ 
Day High $17.50    P/E N/A 
Day Low $16.14    EPS $ 
Volume 4,414,410